Skip to content
Research Article Open access CC BY 4.0

Analysis of Immunohistochemical Markers (Bcl-2 and Ki-67) Expression in Various Endometrial Lesions among Women Presenting with Abnormal Uterine Bleeding

Aruna Geethanjali R, Kalaivani P, Rajkumar P, Devaki Priyanka R

International Journal of Research and Reports in Gynaecology · pp. 172–178 · Published 28 Dec 2024

10.9734/ijrrgy/2024/v7i1111

Abstract

Background: Abnormal uterine bleeding (AUB) has been increasingly reported, with its underlying mechanisms linked to cell proliferation and apoptosis. This study assessed the expression of anti-apoptotic marker (Bcl-2) and proliferative marker Ki-67 in cyclical and abnormal endometrium. Methods: This was a cross-sectional study conducted among women with the clinical history of AUB, adequate clinical details and adequate endometrial specimens received in the form of endometrial curettage and endometrial biopsy. Immunostaining for Bcl – 2 and Ki – 67 markers were done on cyclical and abnormal endometrial lesions followed by scoring based on number of cells and intensity of staining. Results: About 200 specimens were included in this study. On IHC, the Bcl-2 expression was highest in proliferative phase with a mean value of 14.96, followed by endometrial carcinoma (13.71), Disordered proliferative endometrium (DOPE) (12.44) and mean of hyperplastic pattern was 10.04 with the lowest mean score of 3.47 in secretory phase. Ki-67 expression was highest in endometrial carcinoma with a mean value of 15.43, followed by hyperplastic pattern of 14.93, proliferative phase of 14.00 and mean value of DOPE was 10.04. The expression of Ki-67 was significantly decreased in secretory phase with a mean score of 2.67. Conclusion: There was an increased expression of both Bcl-2 and Ki-67 in the proliferative phase while it was minimal in secretory phase in cyclical endometrium. When Bcl-2 and Ki-67 staining were assessed in abnormal endometrium, there was an increased proliferative activity and increased anti-apoptotic activity in disordered proliferative endometrium, hyperplasia and endometrial carcinoma.

Abnormal uterine bleeding endometrial lesions Immunohistochemistry Bcl-2 and Ki-67 expression

References (10)

  1. 1 Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review [DOI]
  2. 2 Apoptosis and apoptosis-related proteins in human endometrium [DOI]
  3. 3 Abnormal uterine bleeding in perimenopause [DOI]
  4. 4 Use of Hysteroscopy in Abnormal Uterine Bleeding: An Edge Over Histopathological Examination [DOI]
  5. 5 The Expression of Apoptosis-Related Proteins Bcl-2 and Ki67 in Endometrium of Ovulatory Menstrual Cycles [DOI]
  6. 6 The Patterns of Expression of an Apoptosis-Related CK18 Neoepitope, the bcl-2 Proto-Oncogene, and the Ki67 Proliferation Marker in Normal, Hyperplastic, and Malignant Endometrium [DOI]
  7. 7 Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP -2 and -9 in endometrial polyps and endometrial cancer type I [DOI]
  8. 8 A histopathological and immunohistochemistry analysis of endometrial lesions among women presenting with abnormal uterine bleeding [DOI]
  9. 9 Abnormal Uterine Bleeding [DOI]
  10. 10 Expression of Ki-67 AND Bcl-2 in Endometrial Hyperplasia [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

45

Page views

0

PDF downloads

10

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.